Keyvanfar, Keyvan

Bmi1 regulates mitochondrial function and the DNA damage response pathway

Liu, J., Cao, L., Chen, J., Song, S., Lee, I. H., Quijano, C., Liu, H., Keyvanfar, K., Chen, H., Cao, L.-Y., et al. (2009) · Nature

Epigenetics and DNA MethylationMitochondrial Function and Pathology

Cited by 474

Deficient CD4+ CD25+ FOXP3+ T regulatory cells in acquired aplastic anemia

Solomou, E. E., Rezvani, K., Mielke, S., Malide, D., Keyvanfar, K., Visconte, V., Kajigaya, S., Barrett, A. J., & Young, N. S. (2007) · Blood

T-cell and B-cell ImmunologyBlood disorders and treatments

Cited by 225

A CD19/CD3 bispecific antibody for effective immunotherapy of chronic lymphocytic leukemia in the ibrutinib era

Robinson, H. R., Qi, J., Cook, E. M., Nichols, C., Dadashian, E. L., Underbayev, C., Herman, S. E. M., Saba, N. S., Keyvanfar, K., Sun, C., et al. (2018) · Blood

Chronic Lymphocytic Leukemia ResearchMonoclonal and Polyclonal Antibodies Research

Cited by 108

IFN-γ-mediated hematopoietic cell destruction in murine models of immune-mediated bone marrow failure

Chen, J., Feng, X., Desierto, M. J., Keyvanfar, K., & Young, N. S. (2015) · Blood

Hematopoietic Stem Cell TransplantationBlood disorders and treatments

Cited by 97

BTK inhibitors, irrespective of ITK inhibition, increase efficacy of a CD19/CD3-bispecific antibody in CLL

Mhibik, M., Gaglione, E. M., Eik, D., Kendall, E. K., Blackburn, A., Keyvanfar, K., Baptista, M. J., Ahn, I. E., Sun, C., Qi, J., et al. (2021) · Blood

Chronic Lymphocytic Leukemia ResearchLymphoma Diagnosis and Treatment

Cited by 30